BTI engineered ENDORET®, a revolutionary regenerative technology designed to deliver personalized treatments. This innovative platform empowers clinicians to address a wide range of pathologies across numerous therapeutic areas, tailoring solutions to individual patient needs and transforming the landscape of modern medicine.
< Regenerative medicine and oral implantologyBTI is a worldwide scientific reference in regenerative medicine, a status earned through the proven success of our proprietary ENDORET® Technology. This widespread recognition stems from its effective application across a diverse range of medical specialties.
The versatility and efficacy of ENDORET® have established BTI as a trusted partner in fields including Dentistry, Traumatology and Sports Medicine, Dermatology, Ophthalmology, Aesthetic Medicine and Reproductive Medicine, among others. Our technology's successful implementation in these and other areas demonstrates our commitment to advancing patient care on a global scale.
Through controlled centrifugation using ENDORET® Technology, pure Plasma Rich in Growth Factors (PRGF), free of leukocytes and erythrocytes, is obtained. Activation with calcium chloride triggers the formation of a fibrin matrix that gradually releases bioactive molecules. These compounds stimulate key cellular processes for over 8 days, promoting tissue regeneration and repair.
ENDORET® is a safe and effective biomedical technology that uses autologous proteins to estimulate the body´s natural ability to repair tissues.
